BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26325507)

  • 21. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
    Rustad EH; Misund K; Bernard E; Coward E; Yellapantula VD; Hultcrantz M; Ho C; Kazandjian D; Korde N; Mailankody S; Keats JJ; Akhlaghi T; Viny AD; Mayman DJ; Carroll K; Patel M; Famulare CA; Op Bruinink DH; Hutt K; Jacobsen A; Huang Y; Miller JE; Maura F; Papaemmanuil E; Waage A; Arcila ME; Landgren O
    Am J Hematol; 2019 Dec; 94(12):1364-1373. PubMed ID: 31571261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable heavy-chain gene analysis of follicular lymphomas: subclone selection rather than clonal evolution over time.
    Aarts WM; Bende RJ; Bossenbroek JG; Pals ST; van Noesel CJ
    Blood; 2001 Jul; 98(1):238-40. PubMed ID: 11418487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma.
    Payne K; Wright P; Grant JW; Huang Y; Hamoudi R; Bacon CM; Du MQ; Liu H
    Br J Haematol; 2011 Oct; 155(1):84-92. PubMed ID: 21790530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
    Kridel R; Chan FC; Mottok A; Boyle M; Farinha P; Tan K; Meissner B; Bashashati A; McPherson A; Roth A; Shumansky K; Yap D; Ben-Neriah S; Rosner J; Smith MA; Nielsen C; Giné E; Telenius A; Ennishi D; Mungall A; Moore R; Morin RD; Johnson NA; Sehn LH; Tousseyn T; Dogan A; Connors JM; Scott DW; Steidl C; Marra MA; Gascoyne RD; Shah SP
    PLoS Med; 2016 Dec; 13(12):e1002197. PubMed ID: 27959929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load.
    Aarts WM; Bende RJ; Steenbergen EJ; Kluin PM; Ooms EC; Pals ST; van Noesel CJ
    Blood; 2000 May; 95(9):2922-9. PubMed ID: 10779440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma.
    Belessi C; Stamatopoulos K; Stavroyianni N; Zoi K; Papadaki T; Kosmas C
    Leukemia; 2001 Nov; 15(11):1772-8. PubMed ID: 11681420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
    Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
    Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell.
    Zelenetz AD; Chen TT; Levy R
    J Exp Med; 1991 Jan; 173(1):197-207. PubMed ID: 1898660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metachronous/concomitant B-cell neoplasms with discordant light-chain or heavy-chain isotype restrictions: evidence of distinct B-cell neoplasms rather than clonal evolutions.
    Wei Q; Sebastian S; Papavassiliou P; Rehder C; Wang E
    Hum Pathol; 2014 Oct; 45(10):2063-76. PubMed ID: 25179408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.
    Fenton JA; Vaandrager JW; Aarts WM; Bende RJ; Heering K; van Dijk M; Morgan G; van Noesel CJ; Schuuring E; Kluin PM
    Blood; 2002 Jan; 99(2):716-8. PubMed ID: 11781262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL.
    Küppers R; Sousa AB; Baur AS; Strickler JG; Rajewsky K; Hansmann ML
    Mol Med; 2001 May; 7(5):285-92. PubMed ID: 11474574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of chimeric DNA of bcl-2 and immunoglobulin heavy chain in follicular lymphoma and subsequent Hodgkin lymphoma from the same patient.
    Nakamura N; Ohshima K; Abe M; Osamura Y
    J Clin Exp Hematop; 2007 Apr; 47(1):9-13. PubMed ID: 17510532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
    Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Fingerprinting of Anatomically and Temporally Distinct B-Cell Lymphoma Samples by Next-Generation Sequencing to Establish Clonal Relatedness.
    Matynia AP; Li KD; Szankasi P; Schumacher J; Liew M; Salama ME; Kelley TW
    Arch Pathol Lab Med; 2019 Jan; 143(1):105-111. PubMed ID: 29979613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients.
    Macintyre EA; Belanger C; Debert C; Canioni D; Turhan AG; Azagury M; Hermine O; Varet B; Flandrin G; Schmitt C
    Blood; 1995 Dec; 86(12):4691-8. PubMed ID: 8541563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.
    Voso MT; Hohaus S; Moos M; Haas R
    Blood; 1997 May; 89(10):3763-8. PubMed ID: 9160682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic evolution of
    Vogelsberg A; Steinhilber J; Mankel B; Federmann B; Schmidt J; Montes-Mojarro IA; Hüttl K; Rodriguez-Pinilla M; Baskaran P; Nahnsen S; Piris MA; Ott G; Quintanilla-Martinez L; Bonzheim I; Fend F
    Haematologica; 2021 Oct; 106(10):2673-2681. PubMed ID: 32855278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
    Haebe S; Shree T; Sathe A; Day G; Czerwinski DK; Grimes SM; Lee H; Binkley MS; Long SR; Martin B; Ji HP; Levy R
    Blood; 2021 May; 137(21):2869-2880. PubMed ID: 33728464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.